典型文献
Expert consensus on drug treatment of chronic subdural hematoma
文献摘要：
Chronic subdural hematoma (CSDH) is a chronic space-occupying lesion formed by blood accumulation between arachnoid and dura mater, which is usually formed in the third week after traumatic brain injury. Surgical treatment is usually the first choice for patients with CSDH having a significant space-occupying effect. Most of the patients showed good results of surgical treatment, but still some patients had a postoperative recurrence (the recurrence rate was up to 33%). Because CSDH is often seen in the elderly, patients are weak and have many basic diseases. The risk of surgical treatment is high; serious complications and even death (the death rate is up to 32%) can often occur. The overall good prognosis rate of patients aged more than 90 years is 24%. The drug treatment can provide a safe and effective treatment for elderly patients who are weak, intolerable to surgery, or failed in surgery. Low-dose and long-term use of atorvastatin (20mg/d) is suggested for continuous treatment for at least 8 weeks, while low-dose and short-term use of dexamethasone can improve the therapeutic effect of atorvastatin on CSDH. Patients should undergo CT or MRI scanning at least one time within 2 weeks after the start of drug treatment.
文献关键词：
中图分类号：
作者姓名：
Zhang Jianning;Chinese Society of Neurosurgery;Chinese Medical Association;Chinese Neurosurgical Critical Care Specialist Council;Collaborational Group of Chinese Neurosurgical Translational and Evidence-based Medicine
作者机构：
Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China.;Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin 300052, China.;Tianjin Key Laboratory of Injuries, Variations and Regeneration of Nervous System, Tianjin 300052, China.;Tianjin Neurological Institute, Tianjin 300052, China.
文献出处：
引用格式：
[1]Zhang Jianning;Chinese Society of Neurosurgery;Chinese Medical Association;Chinese Neurosurgical Critical Care Specialist Council;Collaborational Group of Chinese Neurosurgical Translational and Evidence-based Medicine-.Expert consensus on drug treatment of chronic subdural hematoma)[J].中华神经外科杂志（英文）,2022(01):51-59
A类：
B类：
Expert,consensus,drug,treatment,chronic,subdural,hematoma,Chronic,CSDH,space,occupying,lesion,formed,by,blood,accumulation,between,arachnoid,mater,which,usually,third,after,traumatic,brain,injury,Surgical,first,choice,patients,having,significant,Most,showed,good,results,surgical,but,still,some,had,postoperative,recurrence,rate,was,Because,often,seen,elderly,are,weak,have,many,basic,diseases,risk,high,serious,complications,even,death,occur,overall,prognosis,aged,more,than,years,provide,safe,effective,who,intolerable,surgery,failed,Low,dose,long,term,atorvastatin,20mg,suggested,continuous,least,weeks,while,low,short,dexamethasone,improve,therapeutic,Patients,should,undergo,scanning,within,start
AB值：
0.547048
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
